PARTNER WITH IONETIX TO BRING LIFE-SAVING cardiac PET TO YOUR PATIENTS
With employee experts, industry partners, and creative financing, Ionetix is committed to helping you seamlessly implement or improve a cardiac PET program.
It’s the lifeblood of a viable cardiac PET program. We’ll help you produce radiopharmaceuticals on-site and on-demand for a price that fits in your budget.
We’re committed to offering creative financing options to make starting or improving a cardiac PET within reach.
We offer a variety of configurable layouts to help integrate into even the most challenging of spaces.
Our regulatory experts will help cut through the red tape so you can implement a cardiac PET program ASAP.
We’ll get you up and running. Our service line training equips administrators, physicians, and technologists to launch and maintain their new system.
Get a timely return on your investment. We’ll help you establish or expand a cardiac PET program with insurers.
We’ll help you get the word out about your new or enhanced cardiac PET program.
Ionetix ION-12 SC is a 12 MeV, 10 μA self-shielded superconducting cyclotron.
On-demand, on-site dose production when you need it, where you need it.
Featuring a patent-protected design based on superconducting magnets to shrink its footprint, the ION-12 SC is a next generation, first-of-its-kind cyclotron representing an order of magnitude improvement over conventional cyclotron technology.
Bringing technology born at MIT to market.
Ionetix Corporation was founded to commercialize superconducting cyclotron technology developed at the MIT Plasma Fusion Laboratory. We’re the first company to apply this innovation to create a compact, affordable, simple-to-operate cyclotron for the production of PET radioisotopes.
We’re confident that our cardiac PET partnership 13N-ammonia program and/or 18F solution will help grow your practice or service line. We look forward to hearing from you.